Tour
Privacy
Donate
Contact Us
Log-in
Follow Us
Find a Trial
Find a Trial
How BCT Matching Works
What You'll Need
Get Started
Making Your Decision
See All Trials
Why Participate
Why Participate
Why Clinical Trials are Important
Treatment Trials
Other Types of Studies
Myths & Facts
Your Rights
Personal Stories
Who We Are
Who We Are
About Us
Our Team
Supporters
BCT for Researchers
BCT for Care Providers
Our Newsletter
Get Involved
Contact Us
Resources
Resources
Clinical Trial Glossary
Breast Cancer Drugs
Research Advocacy
Our Newsletter
Other Resources
FAQs
FAQs
BCT FAQs
Privacy Policy FAQs
Clinical Trial FAQs
Home
HELP
/
AYUDA
/
求助
:
help-desk@bctrials.org
/
(888) 282-7099
Print
Other options
See All Trials
Home
view
Contact Information
Return to Trials
Contact Information for Gedatolisib, Ibrance and Faslodex Before Surgery in Women With ER+ HER2- Breast Cancer
Connect
BreastCancerTrials.org
499 Illinois Ave, Suite 200
San Francisco, CA 94158
(888) 282-7099
Help-Desk@bctrials.org
Follow us on
Site Map
Find a Trial
How BCT Matching Works
What You'll Need
Get Started
Making your Decision
- Questions for Doctors
- Questions for Researchers
- Financial Concerns
See All Trials
Why Participate
Why Trials are Important
Treatment Trials
Other Types of Studies
Myths & Facts
Your Rights
Personal Stories
Who We Are
About Us
Our Team
Supporters
BCT for Researchers
BCT for Care Providers
Our Newsletter
Get Involved
Contact Us
FAQs
BreastCancerTrials.org
Privacy Policy
Clinical Trial
s
Resources
Clinical Trial Glossary
Breast Cancer Drugs
Research Advocacy
Our Newsletter
Other Resources
© 2024 Quantum Leap Healthcare Collaborative.
All rights reserved. No portion of this website may be reproduced, copied, or in anyway reused without written permission from BreastCancerTrials.org
Design:
HD
SF
